Dr. Jay Deep Sengupta, MD

Dr. Sengupta practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.

Dr. Sengupta's NPI, 1821213562, was assigned on April 16, 2007. Dr. Sengupta graduated from Texas Tech University Health Science Center School of Medicine in 2004. Dr. Sengupta holds Minnesota license 55456.

Dr. Sengupta's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.

Dr. Sengupta's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Sengupta is also affiliated with Saint Francis Regional Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Sengupta to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sengupta practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Sengupta's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Sengupta is licensed in Minnesota.

CMS data shows 2,011 Medicare services from Dr. Sengupta across 21 procedure codes in 2024, for 628 Medicare patients. Medicare paid $118,493 for them.

CMS counts 628 Medicare patients who saw Dr. Sengupta in 2024. The largest group is 75 to 84, with 255 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sengupta's median patient age at 71, with 46% women.

In 2024, Dr. Sengupta wrote 1,962 Medicare Part D claims for 409 patients. 69% of them were for generic drugs. CMS names the drug for 1,817 of them, across 24 drugs with 11 or more claims each, at $778,456 in total drug cost. In 2023, CMS named 1,652 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sengupta for performance year 2024, reported as part of a group. Dr. Sengupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sengupta as offering telehealth. CMS counts 39 procedures of pacemaker insertion or repair by Dr. Sengupta, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Sengupta, published from 2012 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Defibrillators, Implantable, Pacemaker, Artificial and Atrial Fibrillation. Dr. Sengupta has published most often in Heart Rhythm. Dr. Sengupta's most frequent co-authors are Raed H. Abdelhadi, MD, Robert George Hauser, MD and Charles C. Gornick, MD.

CMS Open Payments shows 46 general payments to Dr. Sengupta from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Boston Scientific Corporation paid the most, $2,533.

Dr. Sengupta graduated from Texas Tech University Health Science Center School of Medicine in 2004.